The Age of Distracti-pression
The pandemic’s true toll on mental health won’t be known for a long time, but data from the past two years indicates a rise — […]
The pandemic’s true toll on mental health won’t be known for a long time, but data from the past two years indicates a rise — […]
The pandemic’s true toll on mental health won’t be known for a long time, but data from the past two years indicates a rise — […]
The pandemic’s true toll on mental health won’t be known for a long time, but data from the past two years indicates a rise — […]
Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming […]
Buzzy start-ups promising easy access to mental health medication found an eager market on social media. Should anyone be looking for treatment on TikTok, though?
Buzzy start-ups promising easy access to mental health medication found an eager market on social media. Should anyone be looking for treatment on TikTok, though?
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más cada similar al consultorio de esta […]
Around the country, the setting for adolescent mental health care looks ever more like this doctor’s office in Kentucky, the next patient arriving every 15 […]
Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain […]
Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to […]
FDA approval of Supernus Pharmaceuticals drug Qelbree gives attention-deficit hyperactivity disorder patients another treatment option that is not classified as a Schedule II substance. It’s […]
Copyright © 2024 | WordPress Theme by MH Themes